Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

No abstract is available for this paper.

• Publication year

  2004

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2004-07-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-004-1177-6PMID 15322938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body Composition Changes in 308 Norwegian HIV-positive Patients

  2004cited by this paper
• The Oslo Health Study: The impact of self-selection in a large, population-based survey

  2004cited by this paper
• Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study

  2003cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction

  2003cited by this paper
• Toxicity of non-nucleoside analogue reverse transcriptase inhibitors.

  2003cited by this paper
• Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Naïve and HIV-Negative Controls: Results from a Norwegian Study of 721 Patients

  2003cited by this paper
• Results of a Phase 2 Clinical Trial at 48 Weeks (AI424-007): A Dose-Ranging, Safety, and Efficacy Comparative Trial of Atazanavir at Three Doses in Combination with Didanosine and Stavudine in Antiretroviral-Naive Subjects

  2003cited by this paper
• Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.

  2003cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction.

  2003cited by this paper
• Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men

  2003cited by this paper
• Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population.

  2003influential reference
• Effect of Tenofovir on Didanosine Absorption in Patients with HIV

  2003cited by this paper
• Impact of HIV infection and HAART on serum lipids in men.

  2003cited by this paper
• RAPID COMMUNICATIONS: MANAGEMENT OF METABOLIC COMPLICATIONS ASSOCIATED WITH ANTIRETROVIRAL THERAPY FOR HIV-1 INFECTION: RECOMMENDATIONS OF AN INTERNATIONAL AIDS SOCIETY-USA PANEL

  2002cited by this paper
• Causes of death among HIV‐infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998–1999

  2002cited by this paper
• Protease inhibitors and cardiovascular outcomes in patients with HIV-1.

  2002cited by this paper
• Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

  2002cited by this paper
• Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia.

  2002cited by this paper
• Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV‐1 Infection?

  2002cited by this paper
• A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.

  2002cited by this paper
• Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study

  2002cited by this paper
• Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.

  2001cited by this paper
• Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

  2001cited by this paper
• Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

  2001cited by this paper
• Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

  2001cited by this paper
• Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

  2001cited by this paper
• Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

  2001cited by this paper
• [Significant decline in blood pressure levels after 1996--fact or artefact?].

  2001cited by this paper
• Interscience Conference on Antimicrobial Agents and Chemotherapy

  2001cited by this paper
• Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects

  2000cited by this paper
• Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.

  1999cited by this paper
• Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS.

  1999cited by this paper
• Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.

  1998cited by this paper
• Protease inhibitor-associated hyperglycaemia.

  1997cited by this paper
• Prevention of coronary heart disease in clinical practice

  1994cited by this paper
• Cardiovascular disease risk profiles.

  1991influential reference
• Dietary influences on serum lipids and lipoproteins.

  1990cited by this paper
• Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county

  1982cited by this paper
• FAST TRACK: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome

  year unknowncited by this paper

• Coronary Artery Disease and Human Immunodeficiency Virus.

  2025cites this paper
• [Human immunodeficiency virus and venous thromboembolism: Role of direct oral anticoagulants].

  2023cites this paper
• CARDIOVASCULAR RISK MEASUREMENT TOOLS IN PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS: A SCOPING REVIEW

  2023cites this paper
• Frecuencia del síndrome metabólico y estratificación del riesgo cardiovascular en pacientes con VIH mediante tres sistemas de puntuación

  2022cites this paper
• Health Challenges and Comorbidities Experienced by People Living with Human Immunodeficiency Virus in Developed Nations: A Systematic Review

  2021influential citation
• Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV

  2021cites this paper
• Contributory role of ART in the development of non-AIDS comorbidities in asymptomatic PLWHA.

  2021cites this paper
• Estimation of the 10-Year Atherosclerotic Cardiovascular Disease and The Framingham Risk Score Among Adults Living with HIV/AIDS in Addis Ababa, Ethiopia: A Hospital-Based, Observational Study.

  2021cites this paper
• Comparison of Predicted Cardiovascular Risk Profiles by Different CVD Risk-Scoring Algorithms between HIV-1-Infected and Uninfected Adults: A Cross-Sectional Study in Tanzania

  2021influential citation
• Recreational Exercising and Self-Reported Cardiometabolic Diseases in German People Living with HIV: A Cross-Sectional Study

  2021cites this paper
• Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study

  2021cites this paper
• Cardiorespiratory Fitness Is Associated With Better White Matter Integrity in Persons Living With HIV

  2021cites this paper
• Are Physical Fitness and CRP Related to Framingham Risk Score in HIV+ Adults?

  2020cites this paper
• Cardiovascular Disorders during HIV-AIDS in the Point G University, Hospital Internal Medical Service

  2020cites this paper
• Cardiovascular Risk Assessment in People Living With HIV: A Systematic Review and Meta-Analysis from Real-Life Data.

  2019cites this paper
• Global Cardiovascular Risk of the HIV Positive Patients Receiving Antiretroviral Therapy in Brazzaville

  2019cites this paper
• Prevalence and Factors Associated with Metabolic Syndrome in People Living with HIV in Parakou in 2016

  2019cites this paper
• Cardiomyopathy and Heart Failure in Patients With HIV Infection.

  2019cites this paper
• Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV.

  2019cites this paper
• Are patients living with HIV infection at risk for not receiving statin medications for cardiovascular disease risk reduction

  2018cites this paper
• Prevalence of arterial hypertension and risk factors among people with acquired immunodeficiency syndrome

  2018cites this paper
• CORRELATION OF CARDIOVASCULAR RISK SCALES WITH CAROTID THICKENING BY B-MODE ULTRASOUND IN PATIENTS WITH HIV

  2018cites this paper
• Relationship between estimated cardiovascular disease risk and insulin resistance in a black African population living with HIV: a cross-sectional study from Cameroon

  2017cites this paper
• High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi

  2017cites this paper
• Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study

  2017cites this paper
• Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease

  2017cites this paper
• Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis

  2017cites this paper
• C-Reactive Protein as an Independent Cardiovascular Risk Predictor in HIV+ Patients: A Focused Review of Published Studies

  2017cites this paper
• Cardiovascular Risk Reduction in Persons Living With HIV: Treatment Development, Feasibility, and Preliminary Results

  2017cites this paper
• Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients

  2017cites this paper
• Physical activity for people living with the human immunodeficiency virus

  2017cites this paper
• Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis

  2016cites this paper
• Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score

  2016cites this paper
• A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon

  2016cites this paper
• Cardiovascular disease risk scores’ relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men

  2016cites this paper
• Cardiovascular Disease Risk Assessment Tools in HIV-Infected Patients - AreThey Adequate?

  2016cites this paper
• Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population

  2016cites this paper
• Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study

  2016cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015influential citation
• Cardiovascular Risk in HIV/AIDS and Lipodystrophy Syndrome Patients

  2015cites this paper
• Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries.

  2015cites this paper
• THE PREVALENCE OF ARTERIAL HYPERTENSION AND ITS RISK FACTORS TOWARD HIV-POSITIVE PERSONS IN FERGANA VALLEY

  2015influential citation
• Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis.

  2015cites this paper
• Exercise and Rehabilitation

  2015cites this paper
• Burden, Determinants, and Pharmacological Management of Hypertension in HIV-Positive Patients and Populations: A Systematic Narrative Review.

  2015cites this paper
• Reply to the editor:.

  2014cites this paper
• Alteraciones del crecimiento y en el estado nutricional de pacientes pediátricos infectados con VIH

  2014cites this paper
• [Metabolic syndrome and cardiovascular risk patients under antiretrovirals in a day hospital at Bobo-Dioulasso (Burkina Faso)].

  2014cites this paper
• Cardiovascular Risk‐Factor Knowledge and Risk Perception Among HIV‐Infected Adults

  2014cites this paper
• Risk of Coronary Heart Disease among HIV-Infected Patients: A Multicenter Study in Brazil

  2013cites this paper
• Reply to the editor.

  2013cites this paper
• Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda

  2013cites this paper
• Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men

  2013cites this paper
• Doença cardiovascular aterosclerótica e a infecção pelo HIV: uma atualização

  2013cites this paper
• Benefícios do exercício físico para pacientes com HIV/AIDS

  2013cites this paper
• Association of Physical Activity with Lipodystrophy Syndrome in HIV- Infected Patients

  2012cites this paper
• Cardiovascular Risk in Patients with HIV Infection

  2012cites this paper
• Rosuvastatin and ciprofibrate in the treatment of dyslipidemia in patients with HIV.

  2012cites this paper
• Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.

  2012cites this paper
• Leitlinie der Pädiatrische Arbeitsgemeinschaft AIDS (PAAD) e.V. zur antiretroviralen Therapie bei HIV-infizierten Kindern und Jugendlichen (2011)

  2012cites this paper
• Cardiovascular Risk Factor Knowledge, Risk Perception, and Actual Risk in HIV-Infected Patients: A Dissertation

  2012influential citation
• Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study

  2012cites this paper
• Prevalencia de fenotipos lipídicos poco aterogénicos en pacientes con VIH, con y sin terapia antirretroviral

  2012cites this paper
• zierten Kindern und Jugendlichen ( 2011 ) Guideline for Antiretroviral Therapy of HIV-Infected Children and Adolescents Grundlagen ▼

  2012cites this paper
• Coronary risk assessment in patients with HIV infection: why bother?

  2012cites this paper
• Dyslipidemia and cardiovascular risk in antiretroviral therapy: management of modifiable factors

  2012cites this paper
• Predicted coronary heart disease risk in croatian HIV infected patients treated with combination antiretroviral therapy.

  2011cites this paper
• Comparación de tres métodos para la estimación del riesgo cardiovascular en una población de pacientes con infección por VIH

  2011cites this paper
• Framingham Risk Score and Early Markers of Atherosclerosis in a Cohort of Adults Infected with HIV

  2011cites this paper
• [Inflammation and HIV].

  2011cites this paper
• Rehabilitation program for the quality of life for individuals on highly active antiretroviral therapy in KwaZulu-Natal, South Africa: a short report

  2011cites this paper
• Cardiovascular risk: anthropometric, clinical and dietary markers in HIV-infected persons

  2011cites this paper
• Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil.

  2011cites this paper
• Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV‐infected Thais

  2011cites this paper
• Comparison Between the Framingham and Prospective Cardiovascular of Münster Scores for Risk Assessment of Coronary Heart Disease in Human Immunodeficiency Virus–Positive Patients in Pernambuco, Brazil

  2010influential citation
• Role of biomarkers in predicting CVD risk in the setting of HIV infection?

  2010cites this paper
• Antipsychotic side effects and monitoring implications

  2010cites this paper
• Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.

  2010cites this paper
• The Association Between Alcohol Consumption and Prevalent Cardiovascular Diseases Among HIV-Infected and HIV-Uninfected Men

  2010cites this paper
• Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV‐infected patients: relationships with serum markers of oxidation and inflammation

  2010cites this paper
• Profile of patients with hypertension included in a cohort with HIV/AIDS in the state of Pernambuco, Brazil.

  2010cites this paper
• Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management

  2010cites this paper
• UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL

  2010cites this paper
• Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study

  2010cites this paper
• Perfil lipídico, fatores de risco cardiovascular e síndrome metabólica em um grupo de pacientes com AIDS

  2009cites this paper
• Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CT.

  2009cites this paper
• VIH, antirtroviraux, dyslipidmie et risque cardiovasculaire

  2009cites this paper
• Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV

  2009cites this paper
• Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy.

  2009cites this paper
• Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients.

  2009cites this paper
• The risk of myocardial infarction during HIV infection treated with antiretroviral combinations. A review

  2009cites this paper
• Microalbuminuria and Hypertension in the HIV-Positive Population of Oslo (MAHO Study)

  2009cites this paper
• Risco cardiovascular pré e pós-terapia antirretroviral potente nos pacientes com síndrome da imunodeficiência adquirida* Cardiovascular risk before and after highly active antiretroviral therapy in acquired immunodeficiency syndrome

  2009cites this paper
• Atteinte cardiovasculaire au cours de l'infection par le VIH

  2009cites this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy:

  2009cites this paper
• Metabolic abnormalities, antiretroviral therapy and cardiovascular disease in elderly patients with HIV.

  2009cites this paper
• Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

  2008cites this paper
• Exercise Training Reduces Central Adiposity and Improves Metabolic Indices in HAART-Treated HIV-Positive Subjects in Rwanda: A Randomized Controlled Trial

  2008cites this paper
• Self-reported low physical function is associated with diabetes mellitus and insulin resistance in HIV-positive and HIV-negative men.

  2008cites this paper
• The human immunodeficiency virus and the cardiometabolic syndrome in the developing world: an African perspective.

  2008cites this paper